Scancell Holdings plc (AIM: SCLP), the developer of ImmunoBody® and Moditope® active immunotherapies to treat cancer, today announces a business update and provides its final audited financial results ...

While Freeport has performed well over the last decade, the company has significantly underperformed the S&P 500 ( SPY) over ...

FPA shares how the Queens Road Small-Cap Value Fund outperformed by focusing on quality small caps and long-term discipline.

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID. Please note: If you switch to a different device, you may be ...